tert-Butyl (1R,5S,9s)-9-amino-3-oxa-7-azabicyclo[3.3.1]nonane-7-carboxylate

Catalog No. :
ACSVKA762
CAS No. :
1932441-42-3
Molecular Formula :
C12H22N2O3
Molecular Weight :
242.32

IUPAC Name:tert-butyl (1R,5S,9r)-9-amino-3-oxa-7-azabicyclo[3.3.1]nonane-7-carboxylate

tert-Butyl (1R,5S,9s)-9-amino-3-oxa-7-azabicyclo[3.3.1]nonane-7-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$440.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (1R,5S,9s)-9-amino-3-oxa-7-azabicyclo[3.3.1]nonane-7-carboxylate
IUPAC Nametert-butyl (1R,5S,9r)-9-amino-3-oxa-7-azabicyclo[3.3.1]nonane-7-carboxylate
MDL No.MFCD25509321
Molecular FormulaC12H22N2O3
Molecular Weight242.32
SMILESCC(C)(C)OC(N1C[C@H]2[C@@]([C@H](COC2)C1)([H])N)=O
InChI KeyQYBPHULJRAEWEO-ILWJIGKKSA-N
Synonym(Meso-1R,5S,9S)-Tert-Butyl 9-Amino-3-Oxa-7-Azabicyclo[3.3.1]Nonane-7-Carboxylate(WX120552);(Meso-1R,5S,9S)-Tert-Butyl 9-Amino-3-Oxa-7-Azabicyclo[3.3.1]Nonane-7-Carboxylate;3-Oxa-7-azabicyclo[3.3.1]nonane-7-carboxylic acid, 9-amino-, 1,1-dimethylethyl ester, (9-syn)-;(1R,5S,9s)-tert-butyl 9-amino-3-oxa-7-azabicyclo[3.3.1]nonane-7-carboxylate
CAS No.1932441-42-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACSVKA762 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSVKA762 route product structure diagram
    ACSVKA7621932441-42-3
Inquiry

2. ACSVKA762 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSVKA762 route product structure diagram
    ACSVKA7621932441-42-3
Inquiry

Comments (0)